Wenwen Zhang

Guangzhou, 510060, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 8 publications

Correction to: ALG3 contributes to stemness and radioresistance through regulating glycosylation of TGF-β receptor II in breast cancer.

Correction to: ALG3 contributes to stemness and radioresistance through regulating glycosylation of TGF-β receptor II in breast cancer.

Journal: Journal of experimental & clinical cancer research : CR

Published: April 01, 2022

ALG3 contributes to stemness and radioresistance through regulating glycosylation of TGF-β receptor II in breast cancer.

ALG3 contributes to stemness and radioresistance through regulating glycosylation of TGF-β receptor II in breast cancer.

Journal: Journal of experimental & clinical cancer research : CR

Published: November 02, 2020

Effectiveness and safety of different amifostine regimens: Preliminary results of a phase II multicenter randomized controlled trial.

Effectiveness and safety of different amifostine regimens: Preliminary results of a phase II multicenter randomized controlled trial.

Journal: Chinese journal of cancer research = Chung-kuo yen cheng yen chiu

Published: July 27, 2018

Feasibility and efficiency of concurrent chemoradiotherapy with a single agent or double agents vs radiotherapy alone for elderly patients with esophageal squamous cell carcinoma: Experience of two centers.

Feasibility and efficiency of concurrent chemoradiotherapy with a single agent or double agents vs radiotherapy alone for elderly patients with esophageal squamous cell carcinoma: Experience of two centers.

Journal: Cancer medicine

Published: June 26, 2018

XPG gene rs751402 C>T polymorphism and cancer risk: Evidence from 22 publications.

XPG gene rs751402 C>T polymorphism and cancer risk: Evidence from 22 publications.

Journal: Oncotarget

Published: May 12, 2017

A Phase II Randomized Controlled Trial: Definitive Concurrent Chemoradiotherapy with Docetaxel Plus Cisplatin versus 5-Fluorouracil plus Cisplatin in Patients with Oesophageal Squamous Cell Carcinoma.

A Phase II Randomized Controlled Trial: Definitive Concurrent Chemoradiotherapy with Docetaxel Plus Cisplatin versus 5-Fluorouracil plus Cisplatin in Patients with Oesophageal Squamous Cell Carcinoma.

Journal: Journal of Cancer

Published: March 13, 2017

miR-1470 mediates lapatinib induced p27 upregulation by targeting c-jun.

miR-1470 mediates lapatinib induced p27 upregulation by targeting c-jun.

Journal: Journal of cellular physiology

Published: September 16, 2014

Overexpression of her-2 associated with the progression of esophageal cancer patients.

Overexpression of her-2 associated with the progression of esophageal cancer patients.

Journal: Hepato-gastroenterology

Published: April 11, 2014

Showing 1-8 of 8

Last Updated: 09/26/2026